Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer.

Subjects

Subjects :

Female
Humans
Time Factors
Treatment Outcome
Antineoplastic Agents, Hormonal administration & dosage
Breast Neoplasms drug therapy
Postmenopause
Tamoxifen administration & dosage

Details

Language :

English

ISSN :

0027-8874

Volume :

89

Issue :

9

Database :

MEDLINE

Journal :

Journal of the National Cancer Institute

Publication Type :

Report

Accession number :

9150193

Full Text :

https://doi.org/10.1093/jnci/89.9.659